SuperX

Cambridge, United Kingdom Founded: 2016 • Age: 10 yrs
Anticoagulation therapeutics without bleeding risk are developed by UK-based SuperX.

About SuperX

SuperX is a company based in Cambridge (United Kingdom) founded in 2016.. SuperX has raised $11 million across 1 funding round from investors including Medicxi and Johnson & Johnson Innovation – JJDC. The company has 2 employees as of September 30, 2018. SuperX operates in a competitive market with competitors including Alexion, argenx, BigHat, Freeline and Kodiak Sciences, among others.

  • Headquarter Cambridge, United Kingdom
  • Employees 2 as on 30 Sep, 2018
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Superx Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $11 M (USD)

    in 1 rounds

  • Latest Funding Round
    $11 M (USD), Series A

    Feb 16, 2017

  • Investors
    Medicxi

    & 1 more

  • Employee Count
    2

    as on Sep 30, 2018

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of SuperX

SuperX has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Series A round of $11 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $11.0M
  • First Round

    (16 Feb 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2017 Amount Series A - SuperX Valuation Medicxi , Johnson & Johnson Innovation – JJDC
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in SuperX

SuperX has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Medicxi and Johnson & Johnson Innovation – JJDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage life science focused VC firm investing in geographies such as Europe and the US
Founded Year Domain Location
Venture capital firm backed by Johnson & Johnson
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by SuperX

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - SuperX

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Superx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of SuperX

SuperX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alexion, argenx, BigHat, Freeline and Kodiak Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for rare and devastating diseases are developed by Alexion.
domain founded_year HQ Location
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
domain founded_year HQ Location
Antibody therapies are developed through machine learning and synthetic biology.
domain founded_year HQ Location
Gene therapy platform is developed for chronic disease treatments.
domain founded_year HQ Location
Therapeutics for retinal diseases are developed by the company.
domain founded_year HQ Location
Developer of monoclonal antibodies against infectious diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Superx

Frequently Asked Questions about SuperX

When was SuperX founded?

SuperX was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is SuperX located?

SuperX is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Is SuperX a funded company?

SuperX is a funded company, having raised a total of $11M across 1 funding round to date. The company's 1st funding round was a Series A of $11M, raised on Feb 16, 2017.

How many employees does SuperX have?

As of Sep 30, 2018, the latest employee count at SuperX is 2.

What does SuperX do?

SuperX was founded in 2016 as an early-stage, virtual biotech in Cambridge, United Kingdom. Focus is placed on discovering antibodies targeting an undisclosed element in the blood coagulation cascade to create anticoagulation therapeutics that avoid bleeding risks. Operations are conducted as a single-asset entity, with incubation at the Babraham Research Campus supporting research activities in the biotech sector.

Who are the top competitors of SuperX?

SuperX's top competitors include argenx, Kodiak Sciences and Scholar Rock.

Who are SuperX's investors?

SuperX has 2 investors. Key investors include Medicxi, and Johnson & Johnson Innovation – JJDC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available